In vitro response of neuromuscular blockers after chronic carbamazepine treatment in rats.
Nguyen
A
A
College of Health Sciences, University of Sydney, Australia.
Ramzan
I
I
D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology*; D001279:Atracurium / Q000494:pharmacology; D002220:Carbamazepine / Q000494:pharmacology*; D003964:Diaphragm / Q000187:drug effects; D066298:In Vitro Techniques; D008297:Male; D009466:Neuromuscular Blocking Agents / Q000494:pharmacology*; D009467:Neuromuscular Depolarizing Agents / Q000494:pharmacology; D009469:Neuromuscular Junction / Q000187:drug effects; D003473:Neuromuscular Nondepolarizing Agents / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D013390:Succinylcholine / Q000494:pharmacology
D000927:Anticonvulsants; D009466:Neuromuscular Blocking Agents; D009467:Neuromuscular Depolarizing Agents; D003473:Neuromuscular Nondepolarizing Agents; D001279:Atracurium; D002220:Carbamazepine; D013390:Succinylcholine